NCT05060536

Brief Summary

To examine whether removing the infrapatellar fat pad from the knee during total knee arthroplasty affects the patient outcome in terms of pain and knee function following the procedure. Currently there is no consensus on whether removing this tissue from the knee has a positive or detrimental effect. Small studies have been published, some showing improved symptoms and some worse symptoms. Current practice of orthopaedic surgeons is either to routinely remove or routinely retain the tissue when performing total knee arthroplasty.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
256

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2021

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 31, 2021

Completed
15 days until next milestone

First Submitted

Initial submission to the registry

September 15, 2021

Completed
14 days until next milestone

First Posted

Study publicly available on registry

September 29, 2021

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

October 13, 2021

Status Verified

September 1, 2021

Enrollment Period

3 years

First QC Date

September 15, 2021

Last Update Submit

October 5, 2021

Conditions

Outcome Measures

Primary Outcomes (9)

  • Knee pain

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    3 months post-operatively

  • Knee pain

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    1 year post-operatively

  • Knee pain

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    2 years post-operatively

  • Knee pain (Anterior)

    As assessed by patient reported outcome scores: Kujala score (0-100) Higher score better outcome.

    3 months post-operatively

  • Knee pain (Anterior)

    As assessed by patient reported outcome scores: Kujala score (0-100) Higher score better outcome.

    1 year post-operatively

  • Knee pain (Anterior)

    As assessed by patient reported outcome scores: Kujala score (0-100) Higher score better outcome.

    2 years post-operatively

  • Knee function

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    3 months post-operatively

  • Knee function

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    1 year post-operatively

  • Knee function

    As assessed by patient reported outcome scores: Oxford knee score (0-48) Higher score better outcome.

    2 years post-operatively

Secondary Outcomes (6)

  • Knee Range of Movement- flexion and extension in degrees

    3 months post-operatively

  • Knee Range of Movement- flexion and extension in degrees

    1 year post-operatively

  • Knee Range of Movement- flexion and extension in degrees

    2 years post-operatively

  • Shortening of patellar tendon- comparison between X-ray at 3 months with pre-operative X-ray

    3 months post-operatively

  • Shortening of patellar tendon- comparison between X-ray at 1 year with pre-operative X-ray

    1 year post-operatively

  • +1 more secondary outcomes

Study Arms (2)

Removal of infrapatellar fat pad

ACTIVE COMPARATOR

When patients will have their fat pad removed.

Procedure: Removal of infrapatellar fat pad

No removal of infrapatellar fat pad

PLACEBO COMPARATOR

When patients will not have their fat pad removed.

Procedure: No removal of infrapatellar fat pad

Interventions

There is no agreed protocol for retaining or excising the infrapatellar fat pad with many surgeons routinely completely removing the fat pad to improve view of the proximal tibia while others opt to retain or minimally excise the tissue. We are aware of no risks involved in performing this procedure and current practice of many orthopaedic surgeons is either to routinely remove or routinely retain the infrapatellar fat pad when performing total knee arthroplasty. The potential benefits are that we will understand better whether removing or retaining this tissue does have a role in influencing outcomes after total knee replacement surgery. The results will be disseminated to the wider orthopaedic community to inform practice with the aim or improving outcomes from total knee arthroplasty.

Removal of infrapatellar fat pad

Retaining the infrapatellar fat pad during total knee replacement- no surgical removal.

No removal of infrapatellar fat pad

Eligibility Criteria

Age40 Years - 100 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male/female patients between 40 and 100 years of age
  • Undergoing primary total knee arthroplasty

You may not qualify if:

  • Patient undergoing unicompartmental knee arthroplasty
  • Patient undergoing revision knee arthroplasty
  • Patient undergoing arthroplasty using non standard implants
  • Previous patella surgery or injury
  • Cognitive impairment
  • Lack of conversational English

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NHS Greater Glasgow and Clyde. Queen Elizabeth hospital (Victoria & Gartnavel)

Glasgow, Scotland, G51 4TF, United Kingdom

RECRUITING

Study Officials

  • Simon Spencer, MBBS. FRCS.

    NHS Greater Glasgow and Clyde Board HQ

    STUDY DIRECTOR

Central Study Contacts

Mairiosa Biddle, MBBS. MRCS.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
double blinded RCT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 15, 2021

First Posted

September 29, 2021

Study Start

August 31, 2021

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

October 13, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations